HA-1A, a genetically engineered antibody used in the treatment of gram-negative bacteremia and septic shock. The antibody binds to bacterial lipopolysaccharide. It is relatively free of side effects.
HA-1A
HA-1A, a genetically engineered antibody used in the treatment of gram-negative bacteremia and septic shock. The antibody binds to bacterial lipopolysaccharide. It is relatively free of side effects.